Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

Name: Medicxi Ventures Management (Jersey) Ltd Q2 2022 13F Filing | 13F Explorer
Creator: Medicxi Ventures Management (Jersey) Ltd
Published: 2022-08-03

Location: St. Helier, Jersey

CIK: 0001715579 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 3, 2022

Total Value: $241M (100.0% shares, 0.0% debt)

Holdings (6)

CNTA CENTESSA PHARMACEUTICALS PLC 40.4%

Value $97.22M Shares 19,963,157 Est. Cost $20.88 Unrealized —

AURA AURA BIOSCIENCES INC 17.9%

Value $43.08M Shares 3,039,892 Est. Cost $17.87 Unrealized -7.4%

PCVX VAXCYTE INC 17.1%

Value $41.07M Shares 1,887,478 Est. Cost $32.16 Unrealized -28.0%

— MERUS N V 15.0%

Value $36.22M Shares 1,600,000 Est. Cost $14.08 Unrealized —

PHAT PHATHOM PHARMACEUTICALS INC 8.6%

Value $20.68M Shares 2,450,679 Est. Cost $22.81 Unrealized -54.9%

— OBSEVA SA 1.0%

Value $2.528M Shares 1,570,000 Est. Cost $3.82 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CNTA	CENTESSA PHARMACEUTICALS PLC	19,963,157	$97.22M	40.4%	$20.88	—	SPONSORED ADS	152309100
AURA	AURA BIOSCIENCES INC	3,039,892	$43.08M	17.9%	$17.87	-7.4%	COM	05153U107
PCVX	VAXCYTE INC	1,887,478	$41.07M	17.1%	$32.16	-28.0%	COM	92243G108
—	MERUS N V	1,600,000	$36.22M	15.0%	$14.08	—	COM	N5749R100
PHAT	PHATHOM PHARMACEUTICALS INC	2,450,679	$20.68M	8.6%	$22.81	-54.9%	COM	71722W107
—	OBSEVA SA	1,570,000	$2.528M	1.0%	$3.82	—	COM	H5861P103